These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24675844)

  • 41. Synthesis, characterization, and biodistribution studies of (99m)Tc-labeled SBA-16 mesoporous silica nanoparticles.
    de Barros AL; de Oliveira Ferraz KS; Dantas TC; Andrade GF; Cardoso VN; Sousa EM
    Mater Sci Eng C Mater Biol Appl; 2015 Nov; 56():181-8. PubMed ID: 26249579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo visualization of MET tumor expression and anticalin biodistribution with the MET-specific anticalin 89Zr-PRS-110 PET tracer.
    Terwisscha van Scheltinga AG; Lub-de Hooge MN; Hinner MJ; Verheijen RB; Allersdorfer A; Hülsmeyer M; Nagengast WB; Schröder CP; Kosterink JG; de Vries EG; Audoly L; Olwill SA
    J Nucl Med; 2014 Apr; 55(4):665-71. PubMed ID: 24614223
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica.
    Gan Q; Lu X; Yuan Y; Qian J; Zhou H; Lu X; Shi J; Liu C
    Biomaterials; 2011 Mar; 32(7):1932-42. PubMed ID: 21131045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preparation and identification of multifunctional mesoporous silica nanoparticles for in vitro and in vivo dual-mode imaging, theranostics, and targeted tracking.
    Chan MH; Lin HM
    Biomaterials; 2015 Apr; 46():149-58. PubMed ID: 25678124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor Targeting Effect of Triphenylphosphonium Cations and Folic Acid Coated with Zr-89-Labeled Silica Nanoparticles.
    Kim GG; Lee JY; Choi PS; Kim SW; Park JH
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32630467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enzyme-coated mesoporous silica nanoparticles as efficient antibacterial agents in vivo.
    Li LL; Wang H
    Adv Healthc Mater; 2013 Oct; 2(10):1351-60. PubMed ID: 23526816
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mesoporous Silica Nanoparticles under Sintering Conditions: A Quantitative Study.
    Silencieux F; Bouchoucha M; Mercier O; Turgeon S; Chevallier P; Kleitz F; Fortin MA
    Langmuir; 2015 Dec; 31(47):13011-21. PubMed ID: 26517311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Di-macrocyclic terephthalamide ligands as chelators for the PET radionuclide zirconium-89.
    Pandya DN; Pailloux S; Tatum D; Magda D; Wadas TJ
    Chem Commun (Camb); 2015 Feb; 51(12):2301-3. PubMed ID: 25556851
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and evaluation of bifunctional tetrahydroxamate chelators for labeling antibodies with
    Rousseau J; Zhang Z; Wang X; Zhang C; Lau J; Rousseau E; Čolović M; Hundal-Jabal N; Bénard F; Lin KS
    Bioorg Med Chem Lett; 2018 Mar; 28(5):899-905. PubMed ID: 29426769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis of mesoporous silica nanoparticles.
    Wu SH; Mou CY; Lin HP
    Chem Soc Rev; 2013 May; 42(9):3862-75. PubMed ID: 23403864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Facile incorporation of aggregation-induced emission materials into mesoporous silica nanoparticles for intracellular imaging and cancer therapy.
    Zhang X; Zhang X; Wang S; Liu M; Zhang Y; Tao L; Wei Y
    ACS Appl Mater Interfaces; 2013 Mar; 5(6):1943-7. PubMed ID: 23363527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intrinsic and Stable Conjugation of Thiolated Mesoporous Silica Nanoparticles with Radioarsenic.
    Ellison PA; Chen F; Goel S; Barnhart TE; Nickles RJ; DeJesus OT; Cai W
    ACS Appl Mater Interfaces; 2017 Mar; 9(8):6772-6781. PubMed ID: 28165700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo tumor vasculature targeted PET/NIRF imaging with TRC105(Fab)-conjugated, dual-labeled mesoporous silica nanoparticles.
    Chen F; Nayak TR; Goel S; Valdovinos HF; Hong H; Theuer CP; Barnhart TE; Cai W
    Mol Pharm; 2014 Nov; 11(11):4007-14. PubMed ID: 24937108
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiolabeling and Imaging of Adoptively Transferred Immune Cells by Positron Emission Tomography.
    Najjar AM
    Methods Mol Biol; 2020; 2097():267-272. PubMed ID: 31776932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multifunctional ZnPc-loaded mesoporous silica nanoparticles for enhancement of photodynamic therapy efficacy by endolysosomal escape.
    Tu J; Wang T; Shi W; Wu G; Tian X; Wang Y; Ge D; Ren L
    Biomaterials; 2012 Nov; 33(31):7903-14. PubMed ID: 22840227
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficient functional delivery of siRNA using mesoporous silica nanoparticles with ultralarge pores.
    Na HK; Kim MH; Park K; Ryoo SR; Lee KE; Jeon H; Ryoo R; Hyeon C; Min DH
    Small; 2012 Jun; 8(11):1752-61. PubMed ID: 22454257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mesoporous silica nanoparticles in nanotechnology.
    Douroumis D; Onyesom I; Maniruzzaman M; Mitchell J
    Crit Rev Biotechnol; 2013 Sep; 33(3):229-45. PubMed ID: 22724458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel Bifunctional Cyclic Chelator for (89)Zr Labeling-Radiolabeling and Targeting Properties of RGD Conjugates.
    Zhai C; Summer D; Rangger C; Franssen GM; Laverman P; Haas H; Petrik M; Haubner R; Decristoforo C
    Mol Pharm; 2015 Jun; 12(6):2142-50. PubMed ID: 25941834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Core
    Ramírez MLÁ; Martínez-Villacorta ÁM; Gómez-Vallejo V; Andreozzi P; Soler-Illia G; Llop J; Moya SE
    Nanoscale Adv; 2022 May; 4(9):2098-2106. PubMed ID: 36133445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.